An Amazon Prime membership almost seems like a necessity these days, as both online shopping and stay-at-home entertainment viewing have picked up dramatically in popularity. Many customers view the ...

News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: PRME) across recent trading sessions. According to data compiled by S&P ...

Prime Medicine announced yesterday a new preclinical program for treating alpha-1 antitrypsin deficiency (AATD), a genetic disorder affecting lung and liver function. The announcement included plans ...

Prime Medicine's Prime Editing offers precise, adaptable, and safer gene-editing treatments, with PM359 for Chronic Granulomatous Disease recently cleared for clinical trials. PRME’s lead drug ...

Last year’s Amazon Prime Day set a record in online spending. The July 8-11 global shopping event is forecast to notch another record, with a $23.8B spend in 2025, potentially topping last year’s ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Prime Medicine, Inc. (NASDAQ:PRME) stands against the other ...

Rate-cut stocks are poised for a strong rally ahead as the Federal Reserve eases its hawkish stance. We’ve seen several months of elevated interest rates combating inflationary pressures. We could see ...